AR071177A1 - Uso de defensinas contra la meningitis - Google Patents
Uso de defensinas contra la meningitisInfo
- Publication number
- AR071177A1 AR071177A1 ARP090101187A ARP090101187A AR071177A1 AR 071177 A1 AR071177 A1 AR 071177A1 AR P090101187 A ARP090101187 A AR P090101187A AR P090101187 A ARP090101187 A AR P090101187A AR 071177 A1 AR071177 A1 AR 071177A1
- Authority
- AR
- Argentina
- Prior art keywords
- meningitis
- polypeptide
- amino acid
- acid sequence
- defensin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente hace referencia a los métodos para tratar la meningitis, tales como la meningitis bacteriana, con polipéptidos defensinas. Reivindicacion 1: Uso de un polipéptido con actividad antimicrobiana, que comprende una secuencia de aminoácidos que tiene al menos 90% de identidad con la secuencia de aminoácidos de SEQ ID Ns 1 para la produccion de un medicamento para el tratamiento terapéutico de la meningitis. Reivindicacion 2: Un polipéptido con actividad antimicrobiana, que comprende una secuencia de aminoácidos que tiene al menos 90% de identidad con la secuencia de aminoácidos de SEQ ID Ns 1 para el tratamiento terapéutico de la meningitis. Reivindicacion 5: El uso, la variante o el método de cualquiera de las reivindicaciones 1-3, donde el polipéptido es un polipéptido defensina, preferiblemente un polipéptido beta-defensina. Reivindicacion 9: El uso, la variante o el método de la reivindicacion 8, donde la meningitis neumococica es causada por una infeccion por Streptococcus pneumoniae resistente a la penicilina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08154103 | 2008-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR071177A1 true AR071177A1 (es) | 2010-06-02 |
Family
ID=40875112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101187A AR071177A1 (es) | 2008-04-04 | 2009-04-03 | Uso de defensinas contra la meningitis |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20090253629A1 (es) |
| EP (1) | EP2278991A1 (es) |
| JP (1) | JP2011516450A (es) |
| KR (1) | KR20100134025A (es) |
| CN (1) | CN102036678A (es) |
| AP (1) | AP2010005403A0 (es) |
| AR (1) | AR071177A1 (es) |
| AU (1) | AU2009231463A1 (es) |
| BR (1) | BRPI0909021A2 (es) |
| CA (1) | CA2720380A1 (es) |
| CL (1) | CL2009000811A1 (es) |
| EA (1) | EA201071163A1 (es) |
| IL (1) | IL208189A0 (es) |
| MX (1) | MX2010010795A (es) |
| PE (1) | PE20091781A1 (es) |
| TW (1) | TW200942254A (es) |
| WO (1) | WO2009121828A1 (es) |
| ZA (1) | ZA201006645B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201028154A (en) * | 2008-10-23 | 2010-08-01 | Novozymes As | Antibiotic synergism |
| TW201125577A (en) * | 2009-12-02 | 2011-08-01 | Novozymes As | Use of defensins for treatment of infective endocarditis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| US20040265337A1 (en) * | 2002-08-21 | 2004-12-30 | Zsebo Krisztina M. | Method of generating an immune response and compositions used for same |
| MX2007005520A (es) * | 2004-11-12 | 2007-07-09 | Novozymes As | Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican los mismos. |
| EP1850861A1 (en) * | 2005-02-08 | 2007-11-07 | Novozymes A/S | Systemic treatment of infections with defensins |
| AU2006256791B2 (en) * | 2005-06-06 | 2012-01-19 | Novozymes Adenium Biotech A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
-
2009
- 2009-03-30 CA CA2720380A patent/CA2720380A1/en not_active Abandoned
- 2009-03-30 EP EP09727630A patent/EP2278991A1/en not_active Withdrawn
- 2009-03-30 WO PCT/EP2009/053726 patent/WO2009121828A1/en active Application Filing
- 2009-03-30 KR KR1020107022668A patent/KR20100134025A/ko not_active Application Discontinuation
- 2009-03-30 EA EA201071163A patent/EA201071163A1/ru unknown
- 2009-03-30 AP AP2010005403A patent/AP2010005403A0/en unknown
- 2009-03-30 MX MX2010010795A patent/MX2010010795A/es not_active Application Discontinuation
- 2009-03-30 JP JP2011502359A patent/JP2011516450A/ja active Pending
- 2009-03-30 CN CN2009801179800A patent/CN102036678A/zh active Pending
- 2009-03-30 BR BRPI0909021A patent/BRPI0909021A2/pt not_active IP Right Cessation
- 2009-03-30 AU AU2009231463A patent/AU2009231463A1/en not_active Abandoned
- 2009-03-31 US US12/414,745 patent/US20090253629A1/en not_active Abandoned
- 2009-04-02 PE PE2009000481A patent/PE20091781A1/es not_active Application Discontinuation
- 2009-04-02 TW TW098110960A patent/TW200942254A/zh unknown
- 2009-04-03 CL CL2009000811A patent/CL2009000811A1/es unknown
- 2009-04-03 AR ARP090101187A patent/AR071177A1/es unknown
-
2010
- 2010-09-16 ZA ZA2010/06645A patent/ZA201006645B/en unknown
- 2010-09-16 IL IL208189A patent/IL208189A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2010005403A0 (en) | 2010-10-31 |
| WO2009121828A1 (en) | 2009-10-08 |
| ZA201006645B (en) | 2011-06-29 |
| MX2010010795A (es) | 2011-01-12 |
| EP2278991A1 (en) | 2011-02-02 |
| CA2720380A1 (en) | 2009-10-08 |
| BRPI0909021A2 (pt) | 2015-09-22 |
| JP2011516450A (ja) | 2011-05-26 |
| US20090253629A1 (en) | 2009-10-08 |
| IL208189A0 (en) | 2010-12-30 |
| PE20091781A1 (es) | 2009-12-03 |
| KR20100134025A (ko) | 2010-12-22 |
| EA201071163A1 (ru) | 2011-04-29 |
| TW200942254A (en) | 2009-10-16 |
| CL2009000811A1 (es) | 2010-05-07 |
| CN102036678A (zh) | 2011-04-27 |
| AU2009231463A1 (en) | 2009-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019001079A1 (es) | Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina. | |
| CL2015001241A1 (es) | Uso de interleucina 2 (il-2) para tratar trastornos inflamatorios o relacionados con la autoinmunidad (div. sol. n° 2608-13) | |
| AR080891A1 (es) | Proteina de fusion robo 1-fc y su utilizacion en el tratamiento de tumores | |
| BR112013026032A2 (pt) | composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida | |
| CL2009000533A1 (es) | Uso de una variante de defensina parenteral contra la tuberculosis; que comprende una sustitucion d9s en el polipeptido maduro; metodo para eliminar o inhibir mycobacterium in vitro. | |
| BR112012018951C8 (pt) | anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica | |
| ES2682670T3 (es) | Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas | |
| BR112016001192A2 (pt) | Vacina contra a raiva | |
| AR090491A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo | |
| BR112013000097A2 (pt) | composições e métodos relacionados a variantes da proteína a (spa) | |
| BR112012018947B1 (pt) | anticorpo anti-caprin-1 monoclonal, composição farmacêutica, combinação farmacêutica e usos de uma composição farmacêutica, de um anticorpo e de uma combinação farmacêutica | |
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| CO2017012454A2 (es) | Secuencias de uricasa adecuadas para el tratamiento de hiperuricemia | |
| BR112013029256A2 (pt) | "combinações farmacêuticas para uso no tratamento de pacientes com diabetes tipo 2, método de tratamento, e usos de lixisenatida e metformina". | |
| BR112015029367A2 (pt) | terapia combinada compreendendo oxazolidinona-quinolonas para uso no tratamento de infecções bacterianas | |
| BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
| BR112013019513A2 (pt) | métodos para o tratamento de úlceras diabéticas do pé | |
| AR083126A1 (es) | Composicion vacunal para el control de las infestaciones por ectoparasitos | |
| AR093182A1 (es) | Metodo para tratar el sobrepeso o la obesidad | |
| BR112018014175A2 (pt) | composição antibacteriana e método para tratar infecções estafilocócicas com a composição antibacteriana | |
| AR091724A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fampridina, composicion farmaceutica | |
| JP2013539776A5 (es) | ||
| BR112019005456A2 (pt) | composição farmacêutica e método para tratamento de esteatose hepática não alcoólica | |
| AR095594A1 (es) | Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos | |
| AR071177A1 (es) | Uso de defensinas contra la meningitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |